Wells says Summit, Akeso data 'not the bull case,' but not 'bear case either' | Markets Insider

Retrieved on: 2025-04-26 01:34:13

Tags for this article:

Lung cancer

TipRanks

Tyrosine kinase receptors

Non-small-cell lung cancer

Anaplastic lymphoma kinase

Ivonescimab

Society of Motor Manufacturers and Traders

Summit Therapeutics

Click the tags to see associated articles and topics

Wells says Summit, Akeso data 'not the bull case,' but not 'bear case either' | Markets Insider. View article details on hiswai:

Excerpt

” The firm would be buyers of Summit and BioNTech (BNTX) on weakness as ... Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech ...

Article found on: markets.businessinsider.com

View Original Article